ATYR
aTYR PHARMA INC
$0.52
-0.02 (-3.44%)
At close · Jul 16
Market Cap
$50.58M
Shares
98,051,212
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-08 | 2026-06-03 | |
| 8-K | 2026-06-01 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-15 | — | |
| 8-K | 2026-05-11 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| DEF 14A | 2026-03-26 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2025-12-05 | 2025-12-04 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| Investor Event Transcript | 2025-09-30 | — | |
| 8-K | 2025-09-15 | — | |
| 8-K/A | 2025-08-08 | 2025-08-07 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-06 | 2025-05-01 | |
| DEF 14A | 2025-03-19 | — | |
| 8-K | 2025-03-13 | — | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-12-12 | 2024-12-10 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-07-22 | — | |
| 8-K | 2024-05-29 | 2024-05-22 | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| DEF 14A | 2024-04-05 | 2024-05-22 | |
| 8-K | 2024-03-14 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-09-26 | — | |
| 8-K | 2023-09-11 | 2023-09-10 | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-05-19 | 2023-05-17 | |
| 8-K | 2023-05-09 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| DEF 14A | 2023-03-29 | 2023-05-17 | |
| 10-K | 2023-03-14 | 2022-12-31 | |
| 8-K | 2023-03-10 | — | |
| 8-K | 2023-03-09 | — |
Showing 1–50 of 105 filings